Cyclophosphamide for salvage therapy of chronic graft-versus-host disease: a retrospective analysis

URN to cite this document:: urn:nbn:de:bvb:355-epub-446076
DOI to cite this document:: 10.5283/epub.44607

Fante, Matthias A. ; Holler, Barbara ; Weber, Daniela ; Angstwurm, Klemens

; Bergler, Tobias ; Holler, Ernst ; Edinger, Matthias ; Herr, Wolfgang ; Wertheimer, Tobias ; Wolff, Daniel

Preview

License: Creative Commons Attribution 4.0
PDF - Published Version
(374kB)

Date of publication of this fulltext: 28 Jan 2021 09:09

Alternative links to fulltext:DOI Publisher

Details

Preview

Indexed in

Export bibliographical data

Abstract

We retrospectively analyzed the safety and efficacy of cyclophosphamide (cyclo) for salvage treatment of chronic graft-versus-host disease (cGvHD) and cGvHD-associated (glomerulo-)nephritis at our center between 01/2010 and 11/2019. We identified 13 patients (pts) receiving cyclo for treatment of moderate (3/13) and severe (6/13) steroid-refractory cGvHD, cGvHD-associated (glomerulo-)nephritis ...